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 Abstract 
As the central nervous system’s (CNS) resident immune cells, microglia help maintain 
the brain as well as facilitate its defenses and repair. Recent research has shown that defects in 
microglia can have consequences on overall brain health and can contribute to the onset and 
progression of neurodegenerative diseases and neurocognitive disorders. These defects can be 
caused by different factors such as age, genetics, pathogens, and the environment. Recent 
research has also shown that gut-brain interactions and communications can have an impact on 
the pathogenesis of several neurological disorders. By performing single labels of tight junction 
proteins ZO1, Occludin, Claudin 3, and Claudin 4 in T84 intestinal epithelial cells, we will be 
able to perform double labels of said proteins in future gut-brain and blood brain barrier 
interaction experiments and improve efficiency of these experiments by reducing the amount of 
materials needed in comparison to performing multiple single labels. 
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Introduction 
Microglia are the central nervous system’s resident macrophages, and they are quite 
sensitive to brain disease and injury. Microglia adopt an activated form by changing their 
structure in response to brain damage, and the structure is ultimately altered by glial 
inflammation. This inflammation has been shown to increase the progression and onset of 
neurodegenerative diseases (1). Along with glial inflammation, disruption of the blood brain 
barrier that leads to blood to brain extravasation of neuroinflammatory molecules may also cause 
an increased risk is neurodegenerative diseases. Increased blood brain barrier permeability, 
which is what can cause blood to brain extravasation, has been shown to decrease tight junction 
protein expression in aged rodents (3), and there is evidence showing that the expression of tight 
junction proteins is impacted by activated microglia (6). Blood brain barrier impairment has also 
been shown to be a factor contributing to Alzheimer’s disease, since the barrier maintains brain 
homeostasis, and with Alzheimer’s, the loss of tight junction proteins is common (4). The 
purpose of my project is to culture T84 cells and achieve successful labels for their tight junction 
proteins ZO1, Occludin, Claudin 3, and Claudin 4. T84 cells are a cancer cell line and were 
collected from the lung metastasis of a 72 year old male’s colon carcinoma (5). By establishing 
proper protocols for the single labeling of these proteins, double labels may be performed in 
future experiments that further involve the impact of tight junction proteins on the blood brain 
barrier and therefore on overall brain health. With double labels, more data may be collected 
with less resources, making the overall experiment more efficient. 
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Methods and Materials  
Labeling tight junction proteins requires a few different protocols, some of which had to 
be changed in order to yield optimal results. To begin the process, T84 cells were maintained in a 
culture flask using advanced DMEM F12 media mixed with 2% Fetal Bovine Serum, 1% 
glutamate and 1% penicillin and streptomycin. When the cells reached an adequate confluency, 
the protocol necessary to culture the cells in a 24-well plate was performed. Around six to seven 
wells were used per plate, and each well had cover slips previously incubated in Poly-D-Lysine 
(PDL). PDL helps the cells attach to the cover slips, and the cover slips are required to visualize 
the cells per microscope later on in the experiment. A hemocytometer was used to count the cells 
present in the culture flask in order to dilute the cells accordingly with media to make sure that 
around 500,000 were present in each well of the plate. Once these dilutions were performed and 
the cells were inputted into the 24 well plates, the plates were cultured for a week with regular 
media changes. After a week, the cells proved confluent enough to experiment on. The cells were 
fixed with paraformaldehyde or methanol, and then incubated with the desired dilution of the 
primary antibody (ZO1, Occludin, Claudin 3, or Claudin 4) for 24 hours. The cells were then 
incubated with an anti-mouse 488 or 594 or an anti-rabbit 488 or 594 secondary antibody for 24 
hours. Keeping double labels in mind, it is important to note that it is vital for secondary 
antibodies to not cross react, meaning they cannot be of the same wavelength or against the same 
species of animal, to be able to visualize the desired tight junction proteins separately. As 
Claudin 4 was the only anti-mouse protein, it was important to get a proper single label of the 
protein to have the opportunity to successfully perform a double label with an 
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anti-rabbit protein (ZO1, Occludin, or Claudin 3) in the future. After the 24 hour secondary 
antibody incubation, the cover slips were incubated with DAPI, which labels cell nuclei, for 24 
hours. Finally, the cover slips were put onto microscope slides to image the cells to see if the 
labeling was successful. It took several different combinations of working primary and 
secondary antibodies, cell fixation methods, and antibody dilutions to produce successful 
labeling for each protein.
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Results 
 
ZO1: This protein was labeled with a Rabbit 488 secondary antibody and later a Rabbit 594 
antibody to make sure both secondary antibodies were viable. Both labels were a 1:100 dilution, 
were incubated with Poly-D-Lysine (PDL), and involved a paraformaldehyde (PFA) cell 
fixation. 
 
Rabbit 488 Label 
Tight Junction                                                           DAPI (nuclei label) 
Tight Junction + DAPI 
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Rabbit 594 Label 
Tight Junction                                                                    DAPI 
 
Tight Junction + DAPI  
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Occludin: This protein was labeled with a Rabbit 488 secondary antibody at a 1:200 dilution. 
The first label performed was with PDL incubation and PFA fixation. The second label was 
without PDL incubation and with methanol fixation.  
 
PDL Incubation and PFA fixation 
 
Tight Junction                                                                    DAPI 
 
 
Tight Junction + DAPI 
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No PDL Incubation and Methanol Fixation 
Tight Junction                                                                   DAPI 
 
Tight Junction + DAPI 
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Claudin 3: This protein was labeled with a Rabbit 488 secondary antibody at a 1:100 dilution. 
This label involved PDL incubation and PFA fixation. 
 
Tight Junction                                                                    DAPI 
 
Tight Junction + DAPI
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Claudin 4: This protein was the most difficult to label and involved a few unsuccessful labels. 
Primary antibody dilutions, the physical primary antibody, and fixation methods were all 
changed to finally produce a successful label. 
 
Unsuccessful Labels: Nonspecific staining 
 
Plate one consisted of a 1:50 and 1:100 dilution, respectively, with PFA fixation, PDL 
incubation, and a Mouse 594 secondary antibody. 
 
 
 
 
 
 
 
 
 
 
 
Plate two consisted of a 1:25 and 1:50 dilution, respectively, with methanol fixation, PDL 
incubation, and a mouse 488 secondary antibody
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Plate three consisted of a 1:50 and 1:100 dilution with PFA fixation, Poly-D incubation, a Mouse 
594 secondary antibody, and a new primary antibody. 
 
 
 
 
 
 
 
 
 
 
Successful Label 
Plate four finally produced a successful label. It involved a 1:100 dilution, PDL incubation, a 
Mouse 594 secondary antibody, a new primary antibody, and methanol cell fixation. 
 
         Tight Junction                                                                DAPI
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Tight Junction + DAPI 
 
 
 
 
 
 
 
 
 
Conclusion 
 Successful single labels of all four of the tight junction proteins ZO1, Occludin, Claudin 
3, and Claudin 4 were achieved. When a plate produced unsuccessful labels, variables such as 
different vials of primary and secondary antibodies, primary antibody dilutions, and fixation 
methods were altered. It was also seen that cover slip incubation with Poly-D-Lysine was not a 
necessarily vital step to get the cells to attach to the cover slip. However, it is still regarded as a 
good measure to take to make sure the labeling goes as smoothly as possible. Claudin 4 was the 
most difficult label to achieve, as it took three unsuccessful plates to finally image a working 
label. Changing the Claudin 4 fixation method from paraformaldehyde to methanol seemed to be 
the solution to get a successful label. Methanol fixation was also attempted on Occludin to see if 
it would be a valid protocol for other tight junction proteins as well. The table below shows all 
the successful labels produced taking into account all the variables that were changed.
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Tight Junction Protein Secondary Antibody Fixation Method Dilution 
ZO1 Rabbit 488 and 594 Paraformaldehyde  1:100 
Occludin Rabbit 488 Paraformaldehyde and 
Methanol 
1:200 
Claudin 3 Rabbit 488 Paraformaldehyde 1:100 
Claudin 4 Mouse 594 Methanol 1:100 
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